Latest news: Anutin (second from left) holding a news conference to give an update on the progress of the ‘ChulaCov19’ vaccine in Bangkok. — Reuters
The country’s second domestically developed vaccine will soon undergo human trials, officials said, adding that the plan was to produce up to five million doses by the end of the year.
The vaccine, developed by Thailand’s Chulalongkorn University, had success in trials in mice and monkeys and is due to be tested on humans in late April or early May, Kiat Ruxrungtham of the Chula Vaccine Research Center said.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
